Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Pharmaceuticals Holdings (comprising US Pharmaceuticals Holdings I, LLC and US Pharmaceuticals Holdings II, LLC) is a specialty pharmaceutical holding company structure established by Wood Creek Capital Management (now Barings LLC, a subsidiary of MassMutual). The company was created to acquire the U.S. commercial rights to mature, established branded prescription drug portfolios from major pharmaceutical companies, including Novartis and Sanofi US. Its portfolio includes well-known products such as Lopressor, Lotensin, Lasix, Demerol, and Parlodel. Validus Pharmaceuticals LLC serves as the exclusive manager and operator of these product lines, handling their manufacturing, distribution, and marketing to meet ongoing clinical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Pharmaceuticals Holdings.